BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38326635)

  • 1. Morphological chest CT changes in cystic fibrosis and massive hemoptysis.
    Dohna M; Kühl H; Sutharsan S; Bruns N; Vo Chieu VD; Hellms S; Kornemann N; Montag MJ
    Radiologie (Heidelb); 2024 Feb; ():. PubMed ID: 38326635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bronchial artery diameter in massive hemoptysis in cystic fibrosis.
    Dohna M; Kühl H; Sutharsan S; Dohna-Schwake C; Vo Chieu VD; Hellms S; Kornemann N; Renz DM; Montag MJ
    BMC Pulm Med; 2022 Nov; 22(1):424. PubMed ID: 36397043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemoptysis and the Risk for Lung Transplant or Death without Transplant in Individuals with Cystic Fibrosis in the United States.
    Bayomy OF; Ramos KJ; Hee Wai T; Kapnadak SG; Morrell ED; Nomitch JT; Pollack LR; Lease ED; Aitken ML; Stephenson AL; Goss CH
    Ann Am Thorac Soc; 2022 Dec; 19(12):1986-1992. PubMed ID: 35759341
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessment of morphological MRI for pulmonary changes in cystic fibrosis (CF) patients: comparison to thin-section CT and chest x-ray.
    Puderbach M; Eichinger M; Haeselbarth J; Ley S; Kopp-Schneider A; Tuengerthal S; Schmaehl A; Fink C; Plathow C; Wiebel M; Demirakca S; Müller FM; Kauczor HU
    Invest Radiol; 2007 Oct; 42(10):715-25. PubMed ID: 17984769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of CFTR modulators on structural lung disease in cystic fibrosis.
    Mok LC; Garcia-Uceda A; Cooper MN; Kemner-Van De Corput M; De Bruijne M; Feyaerts N; Rosenow T; De Boeck K; Stick S; Tiddens HAWM
    Front Pharmacol; 2023; 14():1147348. PubMed ID: 37113757
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison between magnetic resonance imaging and computed tomography of the lung in patients with cystic fibrosis with regard to clinical, laboratory, and pulmonary functional parameters.
    Renz DM; Scholz O; Böttcher J; Maurer MH; Denecke T; Schwarz C; Pfeil A; Streitparth F; Huppertz A; Mehl A; Poellinger A; Staab D; Hamm B; Mentzel HJ
    Invest Radiol; 2015 Oct; 50(10):733-42. PubMed ID: 26154442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HRCT and MRI of the lung in children with cystic fibrosis: comparison of different scoring systems.
    Sileo C; Corvol H; Boelle PY; Blondiaux E; Clement A; Ducou Le Pointe H
    J Cyst Fibros; 2014 Mar; 13(2):198-204. PubMed ID: 24095209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preprocedural planning with prospectively triggered multidetector row CT angiography prior to bronchial artery embolization in cystic fibrosis patients with massive hemoptysis.
    Hayes D; Winkler MA; Kirkby S; Capasso P; Mansour HM; Attili AK
    Lung; 2012 Apr; 190(2):221-5. PubMed ID: 22037830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del).
    Southern KW; Murphy J; Sinha IP; Nevitt SJ
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD010966. PubMed ID: 33331662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del).
    Heneghan M; Southern KW; Murphy J; Sinha IP; Nevitt SJ
    Cochrane Database Syst Rev; 2023 Nov; 11(11):CD010966. PubMed ID: 37983082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automatic bronchus and artery analysis on chest computed tomography to evaluate the effect of inhaled hypertonic saline in children aged 3-6 years with cystic fibrosis in a randomized clinical trial.
    Chen Y; Lv Q; Andrinopoulou ER; Gallardo-Estrella L; Charbonnier JP; Caudri D; Davis SD; Rosenfeld M; Ratjen F; Kronmal RA; Stukovsky KDH; Stick S; Tiddens HAWM;
    J Cyst Fibros; 2023 Sep; 22(5):916-925. PubMed ID: 37246053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise as an Airway Clearance Technique in people with Cystic Fibrosis (ExACT-CF): rationale and study protocol for a randomised pilot trial.
    Urquhart DS; Cunningham S; Taylor E; Vogiatzis I; Allen L; Lewis S; Neilson AR; Soilemezi D; Akooji N; Saynor ZL
    NIHR Open Res; 2022; 2():64. PubMed ID: 37881306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung morphology assessment of cystic fibrosis using MRI with ultra-short echo time at submillimeter spatial resolution.
    Dournes G; Menut F; Macey J; Fayon M; Chateil JF; Salel M; Corneloup O; Montaudon M; Berger P; Laurent F
    Eur Radiol; 2016 Nov; 26(11):3811-3820. PubMed ID: 26843010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Elexacaftor-Tezacaftor-Ivacaftor on lung disease in cystic fibrosis.
    Gushue C; Eisner M; Bai S; Johnson T; Holtzlander M; McCoy K; Sheikh S
    Pediatr Pulmonol; 2023 Aug; 58(8):2308-2316. PubMed ID: 37222417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchial artery embolization for hemoptysis in adult patients with cystic fibrosis: a single-center retrospective study.
    Roussel A; Sage E; Roux A; Guth A; Mellot F; Gravel G
    Acta Radiol; 2023 Apr; 64(4):1381-1389. PubMed ID: 36802809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extrapleural bronchial artery ligation for life-threatening hemoptysis in cystic fibrosis--a case report.
    Kaukuntla HK; Amer KM; Honeybourne D; Stableforth DE; Khalil-Marzouk JF
    Angiology; 2000 Sep; 51(9):787-92. PubMed ID: 10999621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of effects of bronchiectasis on bronchial artery diameter with multidetector computed tomography.
    Kosar M; Kurt A; Keskin S; Keskin Z; Arslan H
    Acta Radiol; 2014 Mar; 55(2):171-8. PubMed ID: 23897305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CF derived scoring systems do not fully describe the range of structural changes seen on CT scans in PCD.
    Tadd K; Morgan L; Rosenow T; Schultz A; Susanto C; Murray C; Robinson P
    Pediatr Pulmonol; 2019 Apr; 54(4):471-477. PubMed ID: 30663844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chest computed tomography outcomes in a randomized clinical trial in cystic fibrosis: Lessons learned from the first ataluren phase 3 study.
    Tiddens HAWM; Andrinopoulou ER; McIntosh J; Elborn JS; Kerem E; Bouma N; Bosch J; Kemner-van de Corput M
    PLoS One; 2020; 15(11):e0240898. PubMed ID: 33141825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.